I am Research Director at Inserm U1027, University of Toulouse 3, Toulouse, France since 2016. I am MD in Epidemiology and Public Health (1993, Bordeaux University), PhD epidemiologist (1996, Bordeaux University), involved in the prevention of mother-to-child transmission research in Africa since 1995, and responsible of the pediatric research program since 2005, at Inserm U897, Bordeaux School of Public Health in Bordeaux, France from 2005 to 2015, then now in the Inserm U1027 team in Toulouse, France, as responsible of a research axis on pediatric infectious diseases in Africa. I have a specific interest in maternal and child health in low-income countries, especially in West-Africa. To date my research has focused on HIV. My main research interests are the burden of this infection in women and during pregnancy, mother-to-child transmission and its prevention, treatment and outcomes in HIV infected children. I was the principal investigator of the MONOD ANRS 12206 clinical trial (ClinicalTrial.gov registry number: NCT01127204), assessing a switch from lopinavir/ritonavir-based ART to efavirenz-based ART. I am currently the scientific responsible of the pediatric IeDEA (International epidemiological Database on AIDS) West African cohort (pWADA) since 2006, studying clinical and health resource utilization outcomes for HIV-exposed children, ART-naive children, and ART-treated children.
